By multivariate analysis , higher peak on-treatment bilirubin levels were found to be associated with the UGT@A@ rs@ T allele ( P = @ ( -@ ) ) , higher baseline hemoglobin levels ( P = @ ( -@ ) ) , higher baseline bilirubin levels ( P = @ ( -@ ) ) , and slower plasma atazanavir clearance ( P = @ ( -@ ) ) .